Mescaline
Learn more about mescaline, the active chemical in peyote and other species of cacti.
This content is made in collaboration with Blossom.
Overview
Common Nicknames
Peyote, peyote buttons, San Pedro
Drug Class
Psychedelic
Drug Form
Button shaped seeds that come from the peyote or San Pedro cactus, dried or mixed with water to form a hallucinogenic drink, a synthetic form of mescaline can also be formulated
Route of Administration
Ingestion via either mixing with water into a drink; dried and crushed to put into capsules which are swallowed; or chewed in the button form. Like other psychedelics it can be microdosed
What is the science of Mescaline?
Mescaline is one of eight psychoactive compounds found in peyote and the San Pedro cactus. Like other classic psychedelics, it is a partial agonist at the serotonergic 5-HT2A and 5-HT2B receptors, but unusually, it is a full agonist at 5-HT2C, meaning it promotes serotonin release in the brain quite strongly. Mescaline is chemically related to amphetamine and produces a strong psychedelic experience, with users typically coming up over a few hours and effects reported to last as long as 14 hours.
One thing that sets mescaline apart from other classic psychedelics is a meaningful degree of activity at dopamine receptors (D1 and D2), something not typically seen with tryptamine psychedelics like psilocybin. This dopaminergic activity may help explain mescaline's particular emphasis on visual beauty, colour saturation and aesthetic or synesthetic qualities, a reported character somewhat distinct from other psychedelics. It also has weak activity at noradrenaline receptors, contributing to physical effects like pupil dilation, a mildly raised heart rate and increased blood pressure.
A typical synthetic dose is in the region of 200 to 400mg, though effective doses from cactus material vary widely depending on the plant's age, growing conditions, and preparation method. Mescaline is relatively resistant to being broken down on its first pass through the liver, and around 55 to 60% is excreted unchanged in urine within 24 hours.
Direct brain imaging research on mescaline itself remains sparse, but, by comparison with LSD and psilocybin, it is expected to increase the diversity of brain activity, disrupt the normal functioning of the default mode network, and increase cross-talk between brain regions that do not usually communicate directly—the same broad pattern seen with other classic psychedelics. Its added dopaminergic activity may produce some subtly different effects on brain activity compared with purely serotonergic psychedelics, though this remains a genuinely open question for future research.
What are the risks?
Because of how mescaline is typically consumed, one can never be sure on the dose taken. If consumed in its natural, chewed form, the potency can vary considerably depending on the climate the cactus grew in and the plant's age, creating a real risk of a more intense experience than expected.
On the physiological side, mescaline has a notably wide margin of safety, given that the extrapolated lethal dose in humans is estimated to sit far above any ceremonial or recreational dose ever likely to be taken, and there are no confirmed deaths attributed to mescaline toxicity alone. That said, mescaline reliably raises heart rate and blood pressure and commonly causes headaches, nausea and vomiting, particularly with cactus preparations. In many indigenous traditions, this nausea and vomiting is understood as a purgative, meaningful part of the ceremony rather than simply a side effect. Anyone with cardiovascular disease, uncontrolled high blood pressure, or who is on blood pressure medication should be cautious. There is also a theoretical, currently unproven concern around mescaline's activity at the 5-HT2B receptor, given that chronic or very frequent use of drugs acting at this receptor has, in other contexts, been linked to heart valve changes, though there's no evidence this occurs with occasional mescaline use specifically.
Anyone with a history of mental illness should be especially cautious with mescaline. Psychedelics put the brain into a temporary neuroplastic state, forming many new connections between neurons and brain regions. This means your surroundings and company can meaningfully shape your general mood and outlook, and your feelings and thoughts will feel more intense than usual, which is exactly why people with a personal or family history of mental illness, including psychotic disorders like schizophrenia, active mania, or seizure disorders, face a higher risk and are generally advised against using mescaline. Even after the experience ends, people with pre-existing mental illness may experience lingering paranoia, anxiety, psychosis or delusions.
There have been conflicting reports on mescaline's effects on foetal development, so it is strongly advised against during pregnancy, even though some indigenous communities do use peyote while pregnant. As with other strongly hallucinogenic psychedelics, there is also a risk of hallucinogen persisting perception disorder (HPPD).
How might the drug make you feel?
Broadly, all psychedelics produce similar symptoms - a general state of mind-altering perception and a dream-like reality. Additionally, mescaline also has quite physical effects, due to increased blood pressure, body temperature, and heart rate. You might experience both visual and auditory hallucinations, thought to derive from the action on the 5-HT2A receptors. This might feel like sounds are warped or at a higher pitch. 3D objects may be subject to geometrisation, and your perception of time and other senses such as smell and touch may change. Mescaline also quite commonly causes headaches, nausea, and vomiting.
Timing-wise, effects generally begin 45 to 90 minutes after ingestion, peak around 2 to 4 hours in, and last roughly 8 to 12 hours overall, with some experiences reported to run as long as 14 hours, notably longer than psilocybin and broadly comparable to LSD.
Is Mescaline addictive, and what are the long-term effects?
You are unlikely to develop a physical dependence on mescaline, but you are quite likely to develop tolerance, meaning you will need more of the drug to reach the same level of psychedelic effect. This can become genuinely dangerous given mescaline's physical effects on heart rate, blood pressure and temperature regulation, since chasing a stronger effect means taking on more physical strain. Tolerance also builds rapidly across different classic psychedelics: recent use of LSD or psilocybin, for example, will similarly blunt mescaline's effects for a period, which naturally limits how often it can be used to meaningful effect. The prominent nausea many people experience, along with the sheer intensity of the experience itself, further discourages frequent, repeated use, and mescaline is not considered a major drug of abuse in population-level data.
There is little evidence that mescaline negatively affects brain function long-term. However, as above, there's a real risk of HPPD, and a negative effect on mental state specifically in users with a history of mental illness.
Harm Reduction and Drug-Drug Interactions
Mescaline is not often cut with other substances and occupies a different market to street drugs like cocaine, which are more commonly adulterated to increase volume, since most users seek out the natural cactus form specifically. That said, mescaline is a powerful drug, and users should always plan out set and setting beforehand. Set refers to your state of mind, keeping thoughts, perceptions and feelings as positive as possible going in, and setting refers to the physical environment you take it in. A trip sitter, someone not taking the drug themselves who helps maintain a calm atmosphere and offers reassurance, is valuable given how suggestible users become. The trip can last longer than 12 hours, so plan around the timing carefully given how long the effects are likely to persist.
Mixing drugs of abuse is never advisable, and everyone reacts differently. Studies have demonstrated interactions between mescaline and both antipsychotics and antidepressants, in which these medications tend to blunt or attenuate mescaline's effects. There is also a reported synergistic effect with 2C-B, a substance that may potentiate mescaline's effects, and user reports suggest cannabis can potentiate psychedelic experiences more generally.
A few specific interactions are worth naming directly. MAOIs can potentiate and meaningfully prolong mescaline's effects by inhibiting how it's broken down in the body, and this combination is generally best avoided outside very specific, deliberately-structured, traditional contexts. Lithium carries a theoretical seizure risk when combined with serotonergic psychedelics including mescaline, and should be avoided. SSRIs and SNRIs may blunt or unpredictably alter mescaline's effects by changing how the relevant serotonin receptors respond, consistent with the attenuation seen with antidepressants more broadly. Combining mescaline with stimulants adds cardiovascular strain on top of mescaline's own effects on heart rate and blood pressure and is not recommended.
Medical Uses
In indigenous communities across the Americas, mescaline has traditionally been used as part of spiritual ritual and ceremony, understood to carry healing or protective qualities. Psychiatrists and scientists have long tried to understand and harness these properties, with some of the earliest formal work in this area coming from Humphry Osmond and Abram Hoffer at Weyburn Mental Hospital in Saskatchewan during the 1950s. They explored mescaline, and later LSD, as an aid to treating alcoholism, helping establish the now-familiar idea that a small number of psychedelic-assisted sessions could produce lasting change, particularly in addiction. One of the few modern controlled studies, published in 1992, gave synthetic mescaline to healthy volunteers under double-blind conditions and confirmed its classic psychedelic profile, including dose-dependent effects and hormonal changes. More recently, an observational study following people using mescaline in naturalistic ceremonial settings found reduced depression and anxiety, and increased connection with nature, at four-week follow-up, though without randomisation or a control group, this can only be read as suggestive rather than conclusive.
Research is growing on whether psychedelics broadly, including mescaline, could work as an adjunct to psychotherapy, using the neuroplastic state the brain enters to help process harmful memories and break negative thinking patterns, an approach of particular interest for conditions like alcohol use disorder and PTSD where early trauma often plays a role. However, unlike psilocybin, which has dozens of active clinical trials underway, there are currently no active Phase II or Phase III clinical trials of mescaline for any psychiatric condition anywhere.
This gap has several causes. Mescaline's long duration makes clinical sessions considerably more resource-intensive to run than shorter psychedelics. Psilocybin offers a similar underlying mechanism with a shorter session and a much larger modern evidence base, making it the more attractive option for the sponsors and researchers currently driving the field forward. And, importantly, mescaline's close association with peyote and protected indigenous religious practice raises genuine cultural and ethical concerns about commercialisation and appropriation, actively being raised by Native American organisations worried about the impact of increased demand on peyote conservation and ceremonial access. As a result, if mescaline-based treatments are developed further, the more responsible and more likely path forward is through synthetic mescaline or newly designed analogues, explicitly separating any future medicine from peyote harvesting and indigenous sacramental supply chains, rather than through peyote-derived material itself.
Myths and Misconceptions
Bad trips can't be ended
The concept of a bad trip is when a psychedelic experience can make you feel anxious, paranoid, and delusional due to the mind-altering properties of the drug. This is what makes ‘set and setting’ so important. Having a trip sitter can help to guide your experience and regulate your emotions, especially if you are in a calm environment.
Mescaline will cause flashbacks
HPPD is always a risk, but the concept of suddenly having an intense trip randomly months or even years after taking psychedelics is highly unlikely.
Mescaline will cause brain damage
Claims that mescaline will cause life changing irreversible brain damage have never been substantiated. Some users do report an altered state of mind or a changed outlook on life but ultimately the effects of mescaline, although intense, are entirely transient.
Mescaline will make you go crazy
Mescaline is considered low risk for most people. It is true that it can trigger psychosis in those pre-disposed to mental health conditions such as schizophrenia, but most users do not experience psychosis after taking the drug.
History
Mescaline's history has to be understood from both an indigenous and a Western scientific perspective, since these tell genuinely different stories about the same compound. It is often called the first psychedelic, used for millennia across the deserts of the Andes, Mexico and the southwestern United States. Archaeological evidence from the Shumla Caves in southwest Texas points to ritual peyote use as far back as roughly 3,700 BCE, making it among the very earliest known psychoactive plants used by humans anywhere. Peyote became deeply embedded in Aztec and Huichol (Wixáritari) spiritual life, and the Huichol pilgrimage to Wirikuta to harvest peyote remains a living, central tradition today. A parallel tradition developed further south, where San Pedro and Peruvian torch cacti have been used by Andean healers for divination and spiritual work for at least two thousand years.
Mescaline's entry into Western science began in 1897, when German chemist Arthur Heffter isolated it from peyote, making it the first psychedelic compound ever to be chemically identified; its total synthesis followed in 1919, making it the first psychedelic ever produced synthetically. In 1928, Heinrich Klüver's systematic study of mescaline-induced visual effects identified recurring geometric patterns, lattices, spirals, tunnels and cobwebs, that became foundational to how hallucinations are studied scientifically across many substances and conditions. The drug then entered wider intellectual life through Aldous Huxley's 1954 book The Doors of Perception, based on his own mescaline experience, and through psychiatrist Humphry Osmond, who coined the very word ‘psychedelic’ while working with mescaline in the 1950s, initially using it within a "model psychosis" framework to help understand schizophrenia.
In 1970, mescaline was placed in Schedule I in the US alongside other classic psychedelics under the Controlled Substances Act, halting most legitimate research and recreational use alike. A narrow federal exception followed via the American Indian Religious Freedom Act of 1978 and its 1994 amendments, which protect the sacramental use of peyote specifically by enrolled members of the Native American Church in genuine religious ceremonies; this protection is deliberately narrow and does not extend to synthetic mescaline or other mescaline-containing cacti.
Unlike psilocybin, LSD and MDMA, mescaline has not significantly shared in the broader modern revival of psychedelic research. Its long duration complicates clinical logistics, its deep ties to protected indigenous and religious practice raise real, ongoing concerns about cultural appropriation that responsible researchers take seriously, and no pharmaceutical company or major research funder has yet taken it forward as a formal development programme. As a result, modern human research on mescaline remains sparse, and its contemporary profile rests far more on its remarkable historical, cultural and ethnobotanical significance than on current clinical evidence, even as recreational use remains illegal in most places despite ongoing use within indigenous communities.
